LEADER 01457nam  2200421   450 
001 000005181
005 20051129115734.0
010   $a2-7010-1454-9
100   $a20000920d2005----km-y0itay0103----ba
101 0 $afre
102   $aFR
200 1 $aMétamorphoses de l'Antichrists chez les Pères de l'Église$fCristian Badilita
210   $aParis$cBeauchesne$dc2005
215   $a557 p.$d22 cm
225 1 $aThéologie historique$v116
410   $12001$aThéologie historique$v116
702  1$aBadilita,$bCristian
801  0$aIT$bUniversità della Basilicata - B.I.A.$gRICA$2unimarc
912   $a000005181
996   $aMétamorphoses de l'Antichrists chez les Pères de l'?gliseglise$91526162
997   $aUNIBAS
BAS   $aMONLET
BAS   $aMONOGR
BAS   $aLETTERE
CAT   $aLOTITO$b01$c20000728$lBAS01$h1232
CAT   $aDILEO$b01$c20000920$lBAS01$h1050
CAT   $aDILEO$b01$c20000920$lBAS01$h1055
CAT   $c20000920$lBAS01$h1833
CAT   $c20001010$lBAS01$h1636
CAT   $c20050601$lBAS01$h1753
CAT   $abatch$b01$c20050718$lBAS01$h1048
CAT   $c20050718$lBAS01$h1107
CAT   $c20050718$lBAS01$h1137
CAT   $c20050718$lBAS01$h1152
CAT   $aMDL$b01$c20051117$lBAS01$h1722
CAT   $aMDL$b30$c20051129$lBAS01$h1157
FMT   
Z30 -1$lBAS01$LBAS01$mBOOK$1BASA1$APolo Storico-Umanistico$2DID$BDidattica$3FM/103575$6103575$5L103575$820051129$f04$FPrestabile Didattica

LEADER 02378nam  22005771  450 
001 9910463771903321
005 20200520144314.0
010   $a1-60805-747-X
035   $a(CKB)2670000000402537
035   $a(EBL)1336319
035   $a(OCoLC)855504888
035   $a(SSID)ssj0001127419
035   $a(PQKBManifestationID)11669035
035   $a(PQKBTitleCode)TC0001127419
035   $a(PQKBWorkID)11150175
035   $a(PQKB)10182177
035   $a(MiAaPQ)EBC1336319
035   $a(Au-PeEL)EBL1336319
035   $a(CaPaEBR)ebr10762668
035   $a(EXLCZ)992670000000402537
100   $a20130810d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aErythropoietic stimulating agents /$feditor, Elisio Costa; co-editors, Flavio Reis and Alice Santos-Silva
210  1$aOak Park, Illinois :$cBentham Science Publishers,$d2013.
215   $a1 online resource (306 p.)
225  0$aFrontiers in drug discovery ;$vv. 1
300   $aIncludes index.
311   $a1-60805-748-8 
327   $aCover; TItle; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chatper 07; Chapter 08; Chatper 09; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Index; Bak Cover
330   $aThis volume includes a revision of articles on erythropoiesis and EPO gene regulation, microRNAs and their potential contribution to the development of new therapeutic strategies, animal models for studying kidney disease-associated anemia as well as benefits/risks of ESA therapy. The biological effects of new ESA molecules, heparin-binding erythropoietin and of pHBSP, and the potential applications of ESA, are also elicited in this volume.
410  0$aFrontiers in Drug Discovery
606   $aErythrocytes
606   $aErythropoiesis$xRegulation
608   $aElectronic books.
615  0$aErythrocytes.
615  0$aErythropoiesis$xRegulation.
676   $a612.111
701   $aCosta$b Elisio$0922583
701   $aReis$b Fla?vio$0922584
701   $aSantos-Silva$b Alice$0922585
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910463771903321
996   $aErythropoietic stimulating agents$92070180
997   $aUNINA